Product Datasheet
|
|
|
Product Description |
|
Product: |
Kininogen, LMW, Human Plasma |
Catalog Number: |
HK-LMW |
Product Page: |
https://www.mol-innov.com/products/IHUKNGSCHMW100UG |
Description: |
LMW Kininogn is involved in blood pressure regulation since it is an endogenous protein substrate for tissue kallikrein. Proteolytic cleavage by kallikrein releases vasoactive bradykinin from LMW kininogen. In addition, LMW kininogen, like HMW kininogen, is a major extracellular cysteine protease inhibitor. Prepared from plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. >95percent pure by SDS-PAGE. Add deionized water to original volume, aliquot and freeze unused portion. |
Recommended Storage: |
SAMPLE |
Minimum Shelf Life: |
232.75 |
Source: |
Lyophilized |
Molecular Weight: |
Proteins |
Extinction Coefficient: |
65,000 |
Antigen: |
-70 C |
Target: |
Lyophilized powder |
Target Molecular Weight: |
KININOGEN |
Host: |
679.25 |
Clonality: |
5 |
Isotype: |
Human plasma |
Applications: |
Cold pack |
Cross-reactivity: |
3 years from delivery |
Concentration: |
245 |
Volume: |
715 |
Titer: |
0.01M Sodium Acetate; 0.25M NaCl; pH 5.5 |
Buffer: |
SAMPLE |
Form: |
0.1 mg |
|
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
|
For in vitro laboratory use only |
|
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |